Cronos Group Inc. (TSX:CRON)
Canada
· Delayed Price · Currency is CAD | Market Cap | 914.25M |
| Revenue (ttm) | 169.23M |
| Net Income (ttm) | 59.11M |
| Shares Out | 382.53M |
| EPS (ttm) | 0.15 |
| PE Ratio | 15.45 |
| Forward PE | 232.49 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 94,118 |
| Average Volume | 581,333 |
| Open | 2.390 |
| Previous Close | 2.370 |
| Day's Range | 2.350 - 2.400 |
| 52-Week Range | 2.270 - 4.280 |
| Beta | 1.42 |
| RSI | 40.92 |
| Earnings Date | May 13, 2025 |
About Cronos Group
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. The company offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. Cronos Group Inc. was founded in 2012 and is based in Stayner, Canada. [Read more]
News
2 Canadian Marijuana Stocks For Your Upcoming Watchlist
Marijuana stocks are torn between two ferns, and this has created a volatile frenzy in the sector. It could be that people feel the cannabis sector will eventually take the behavior of other sectors w...
3 Canadian Marijuana Stocks For Long-Term Investing
Marijuana stock investors are torn between several paths. With how volatile the space is, much of the sector is trading at low price points. It is almost safe to say that more than half of those who h...
Top Canadian Cannabis Stocks to Watch in April 2025
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue str...
Marijuana Stock Movers For March 24, 2025
GAINERS: Affinor Growers (OTC: RSSFF) shares closed up 19.75% at $0.05 Blueberries Medical (OTC: BBRRF) shares closed up 16.25% at $0.01 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 11.98% at ...
Cronos Stock: Win Big Or Lose All
I maintain a 'strong buy' rating for Cronos, despite regulatory headwinds, due to its strong fundamentals and potential for multibagger returns. Cronos has shown positive progress with a robust cash b...
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U....
Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna ...
Cronos Group Inc. (CRON) 37th Annual Roth Conference (Transcript)
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Ch...
Cronos Reports Improved Q4-2024 Financials With Revenues From GrowCo
Cronos reported 27% increase in revenues YOY for Q4-2024. The company is now reporting revenues from its 50% ownership of GrowCo. The company reported increasing profits and free cash flow for the qua...
Top Marijuana Stocks To Know In Today's Stock Market 2025
As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader c...
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
On Thursday, Cronos Group Inc (NASDAQ: CRON) reported fourth-quarter sales of $30.3 million, up from $23.92 million, missing the consensus of $34.95 million . The increase year-over-year was primaril...
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
On Thursday, Cronos Group Inc CRON reported fourth-quarter sales of $30.3 million, up from $23.92 million, missing the consensus of $34.95 million.
Cronos Group (CRON) Q4 2024 Earnings Call Transcript
CRON earnings call for the period ending December 31, 2024.
Cronos Group Inc. (CRON) Q4 2024 Earnings Call Transcript
Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap
Stocks in the cannabis sector notched notable gains on Thursday, according to Benzinga Pro data, with Cronos Group (NASDAQ: CRON) up 3.82%, Verano Holdings (OTC: VRNOF) up 1.11%, Trulieve (OTC: TCNN...
Cronos Group Inc (CRON) Q4 2024 Earnings: Revenue at $30. ...
Cronos Group Inc (CRON) Q4 2024 Earnings: Revenue at $30.3M Misses Estimates, Net Income Reaches $43.9M
Cronos Group GAAP EPS of $0.11 beats by $0.12, revenue of $30.3M misses by $4.54M
Cronos Group Reports 2024 Fourth Quarter and Full-Year Results
Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million
Earnings Scheduled For February 27, 2025
Companies Reporting Before The Bell • Hafnia (NYSE: HAFN) is estimated to report earnings for its fourth quarter. • argenx (NASDAQ: ARGX) is projected to report quarterly earnings at $1.06 per share...
Cronos Group Q4 Earnings Preview
Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025
TORONTO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday...
3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise
The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no f...
Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing
Cannabis stocks tend to move on speculation around potential federal reforms around pot.
Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are p...